{
  "id": 2467654,
  "title": "Neumora Therapeutics COO Aurora disposes of $269,966 in stock",
  "url": "https://urgent.news/2026/08/22/neumora-therapeutics-coo-aurora-disposes-of-269-966-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-22T01:16:14.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/neumora-therapeutics-coo-aurora-disposes-of-269966-in-stock-93CH-4872250"
  },
  "original_language": "en",
  "account": "Daljit Singh Aurora, the Chief Operating and Development Officer at Neumora Therapeutics, Inc. (NASDAQ:NMRA), disposed of a significant amount of company stock on August 20 and 21, 2026. Aurora sold 176,060 shares at prices ranging between $1.48 and $1.6393, a total worth approximately $269,966. Prior to these sales, Aurora acquired an equal number of shares via option exercises, valued at around $126,763 at an exercise price of $0.72 per share. The current stock price of NMRA is $1.63, marking a substantial decline from its 52-week high of $3.65, with a -51.92% return over the past six months. Despite this, InvestingPro analysis suggests the company is slightly undervalued at present.",
  "summary": null,
  "key_points": [
    "COO Aurora sold 176,060 Neumora shares on Aug 20-21, 2026",
    "Disposition valued at $269,966 at $1.48-$1.6393 per share",
    "NMRA stock down 51.92% over 6 months, currently $1.63"
  ],
  "editors_take": "The sale of a significant amount of Neumora Therapeutics stock by its COO suggests a potential loss of confidence in the company's near-term prospects by a key insider.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}